The evidence is undeniable. The increase in Zoom and FaceTime meetings has prompted a surge in demand for non-invasive injectables and fillers worldwide.
The desire for younger-looking healthy skin is at an all-time high and is also fast-tracking the anti-ageing treatment sector.
According to Coherent Market Insights, the global market intelligence and consultancy firm, the top two categories in the worldwide anti-ageing market are anti-wrinkle serums, moisturisers and treatments and botulinum toxin injections.
The global anti-ageing market is currently valued at US$21.06 billion. But over the next five years it is expected to grow to US$34.49 billion – a CAGR of 7.3 per cent.
Topical products such as serums and creams have the largest market share at 45.9 per cent, followed by anti-stretchmark products, sunscreens and naturals, notes Coherent Market Insights.
Botulinum toxin injections from leading brands such as Botox, Dysport, Xeomin and Jeuveau have the biggest market share of the global aesthetics market, followed by dermabrasion, microdermabrasion, chemical peels, fractional laser resurfacing, dermal fillers and non-ablative rejuvenation.
The top companies in the global anti-ageing market include: Allergan (the maker of Botox), The Estée Lauder Companies, Shiseido, Beiersdorf (the parent company of Nivea and La Prairie), L’Oréal, NuFACE (the microcurrent facial toning device brand) and Rodan + Fields, the #1 skincare brand in the US with more than 2 million customers in the US, Canada and Australia.